Akoya Biosciences, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Akoya Biosciences files an amendment to its 2024 Annual Report on Form 10-K to include information required by Part III, covering directors, executive officers, compensation, and corporate governance.
Akoya Biosciences reports a net loss for 2024 but highlights its leading position in the spatial biology market and a pending merger with Quanterix.
Akoya Biosciences, a leader in spatial biology, announced its full year 2023 results, showcasing a 29% revenue increase and a 27% expansion of its installed instrument base.